Copyright © Bayer CropScience Ltd.
Bayer CropScience Limited
UNAUDITED FINANCIAL RESULTS FOR THE PERIOD ENDED 30TH SEPTEMBER, 2008
Rs. in Lacs
PARTICULARS
THREE MONTHS
ENDED
30th SEPTEMBER
2008

CORRESPONDING
THREE MONTHS
ENDED
30th SEPTEMBER 2007
IN THE PREVIOUS
YEAR
YEAR TO DATE
FIGURES FOR
THE PERIOD
ENDED
30th SEPTEMBER
2008
YEAR TO DATE
FIGURES FOR
THE PREVIOUS
YEAR FROM 1st
JANUARY 2007
TO 30th SEPTEMBER
2007
PREVIOUS
ACCOUNTING
PERIOD FROM
1st JANUARY 2007
TO 31st MARCH
2008
Income   .
.
   
Net Sales/ Income from Operations
41,596
35,237
89,097
78,950
116,335
Other Income
1,918
1,552
3,955
4,210
7,497
Total Income
43,514

36,789
93,052
83,160
123,832
 
Expenditure
(Increase)/ Decrease in Stock in Trade and Work in Progress
3,109
2,001
(5,372)
(3,324)
(1,065)
Consumption of Raw Materials
12,215
7,475
19,880
19,235
31,781
Purchase of traded goods
10,154
12,023
44,203
37,076
46,518
Employees cost
3,234
2,305
6,327
6,442
12,217
Depreciation
567
513
1,153
1,536
2,612
Impairment loss of fixed assets (net)
-

-
.
-
16
Other Expenditure
6,836
5,186
14,437
14,526
25,563
Total Expenditure
36,115
29,503
80,628
75,491
117,642
     
.
   
Profit from Operations before Other Income, Interest and Exceptional Items
7,399
7,286
12,424
7,669
6,190
  .  
.
   
Other Income
786
569
1,282
1,527
2.304
 
.
.
.
.
.
Profit before Interest and Exceptional Items
8,185
7,855
13,706
9,196
8,494
      .    
Interest
279
103
411
288
589
      .    
Profit after interest but before exceptional Items
7,906
7,752
13,295
8,908
7,905
      .    
Exceptional Items (net)
-
2,780
-
839
1,110
 
.
.
..
.
.
Profit from Ordinary Activities before tax
7,906
7,752
13,295
8,069
6,795
      .    
Tax Expense (including Deferred Tax and Fringe Benefit Tax)
2,800
1,663
4,715
2,431
1,885
      .    
Net Profit from Ordinary Activities after tax
5,106
3,309
8,580
5,638
4,910

.
.
.
.
.
Paid up Equity Share Capital (Face Value Rs. 10)
3,950
3,950
3,950
3,950
3,950
. . .
.
. .
Reserves excluding Revaluation Reserve as per Balance sheet of previous accounting year
-
-
-
-
32,994
.
.
.
.
.
.
Earning Per Share (basic & diluted) (not annualised)
12.93

8.38
21.72
14.27
12.43
Public Shareholding.
Number of shares
11,412,085
11,412,085
11,412,085
11,412,085
11,412,085
Percentage of shareholding (%)
28.89%
28.89%
28.89%
28.89%
28.89%

Notes:
1. The above results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 21st October, 2008 and the statutory auditors have carried out a limited review of the results for the quarter and six months ended 30th September, 2008.

2. In accordance with the past practice consistently followed, Sales for the six months ended 30th September, 2008 are net of estimated returns of Rs. 2,626 lacs (Jan - September 2007 Rs. 1,260 lacs), in respect of seasonal sales which in Management's opinion, may need to be reviewed dependant on future circumstances. Further, sales returns are accounted at actuals at the financial year end.

3. Exceptional Items for -
(a) the quarter and nine months ended 30th September, 2007 includes Rs. 2,780 lacs and the fifteen months ended 31st March, 2008 includes Rs. 3,050 lacs on account of Voluntary Retirement offered to and accepted by 109 and 119 employees at Thane respectively.
(b) the nine months ended 30th September, 2007 and fifteen months ended 31st March, 2008, includes profit of Rs. 1,555 lacs and Rs. 385 lacs on sale of equity shares in Bayer Diagnostics India Limited and Bayer Polychem (India) Limited, respectively

4. The Company has only one reportable business segment, i.e. “Agri Care”.

5. There were no investor complaints pending at the beginning and at the end of the quarter. During the quarter, no investor complaints were received.

6. The previous accounting year being fifteen months ended 31st March, 2008, year to date figures for current period are six months while previous period's figures are for nine months and hence, such figures are not comparable.

7. Previous period’s figures have been regrouped wherever necessary.

 

Place: New Delhi
Date: 21st October, 2008

 

 

By Order of the Board

Kaikobad B. Mistry
Director